Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
2 hedge funds and large institutions have $1.5M invested in Abiomed Inc in 2023 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 6 closing their positions.
68% less capital invested
Capital invested by funds: $4.62M → $1.5M (-$3.12M)
75% less funds holding
Funds holding: 8 → 2 (-6)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Top Buyers
Top Sellers
ABMD Hedge Fund Activity: Q1 2023 in Review
2 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q1 2023, worth a combined $1.5M — down 68% from $4.62M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ABMD and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Blue Trust Inc, exiting entirely with an estimated $1.21M sold.
- 2 institutional investors held Abiomed Inc (ABMD) as of Q1 2023, down from 8 in Q4 2022.
- Funds reported $1.5M of Abiomed Inc stock for Q1 2023, down 68% quarter-over-quarter.
- 0 funds opened new Abiomed Inc positions in Q1 2023 and 6 closed out, a net change of -6 holders.
- The largest Abiomed Inc seller in Q1 2023 was Blue Trust Inc, an estimated $1.21M sold.
Based on aggregated 13F filings for Q1 2023.